INDSWFTLAB vs WANBURY: Stock Comparison

Ind-Swift Laboratories Limited vs Wanbury Ltd

Live data: 22 July 2026, 2:56 PM IST • Source: NSE and company filings

Ind-Swift Laboratories Limited is the larger company by market capitalisation. Ind-Swift Laboratories Limited shows lower leverage and a higher net margin, while Wanbury Ltd shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Ind-Swift Laboratories Limited and Wanbury Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, INDSWFTLAB is more favourable on 2 of 13 scored metrics and WANBURY on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
INDSWFTLAB is the larger company
₹2,035 Cr vs ₹1,140 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 50.25x
P/B Ratio
WANBURY has a lower P/B
0x vs 1.5x
EPS
WANBURY has higher earnings per share
₹13.1 vs ₹4.84
Revenue Growth (TTM YoY)
WANBURY has faster revenue growth
-19.2% vs -66.6%
EPS Growth (TTM YoY)
WANBURY has faster EPS growth
0% vs -94.8%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
24.5% vs 22.8%
Qtr Profit Growth
WANBURY has stronger quarterly profit growth
1,197% vs 9.35%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricINDSWFTLABWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricINDSWFTLABWANBURY
Live Price₹233.86₹328
Day Change-1.57%-3.07%
Volume3.83 L4.34 L
52-Week High₹248.45₹358.85
52-Week Low₹87.15₹161.5
Distance from 52W High-5.87%-8.6%

Valuation

MetricINDSWFTLABWANBURY
Market Cap₹2,035 Cr₹1,140 Cr
P/E Ratio50.25x0x
P/B Ratio1.5x0x
EPS₹4.84₹13.1
Book Value₹165.77₹18.1
Dividend Yield0%0%

Growth

MetricINDSWFTLABWANBURY
Revenue Growth (TTM YoY)-66.6%-19.2%
EPS Growth (TTM YoY)-94.8%0%
Qtr Sales Growth22.8%24.5%
Qtr Profit Growth9.35%1,197%

Profitability & Leverage

MetricINDSWFTLABWANBURY
ROE3.87%76.5%
ROCE4.7%36.6%
Net Margin41.4%10.17%
Operating Margin7.03%14%
Debt to Equity0.01x3.02x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricINDSWFTLABWANBURY
Promoter Holding42.99% 3.49 pp34.36%
FII Holding13.88% 0.45 pp0.89% 0.3 pp
DII Holding0% 0.68 pp0.06% 0.06 pp
Public Holding43.12% 2.38 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ind-Swift Laboratories Limited and Wanbury Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.